Genetics CME

Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors
Susana Banerjee, MBBS, MA, FRCP, PhD
May 7, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Karl E. Anderson, MD
April 15, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer
March 9, 2021
Medical Learning Institute, Inc.
Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications
Emmanuel S. Antonarakis, MD
July 22, 2020
Medical Learning Institute, Inc.
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
June 3, 2020
Medical Learning Institute, Inc.
Targeting Pathogenic Mutations in the DNA Damage Response Pathway: Genetic Testing and Counseling in the Era of Precision Medicine and Next-Generation Sequencing
Mike Janicek, MD / Bradley J. Monk, MD, FACS, FACOG
May 27, 2020
Medical Learning Institute, Inc.
Novel Strategies and Emerging Evidence to Address Unmet Needs in Treating Patients With Long-Chain Fatty Acid Oxidation Disorders
Jerry Vockley, MD, PhD
January 31, 2020

Education Collections